Moving in on immunosuppression in the new millennium Helen Commander Newsletter Article 06 February 2013 Pages: 3 - 4
Secondary prevention of coronary heart disease less than ideal Newsletter Article 06 February 2013 Pages: 5 - 5
Rotavirus vaccination programme cost effective in the US Newsletter Article 06 February 2013 Pages: 8 - 8
Consider alternative interventions to interferon-β-1b for MS Newsletter Article 06 February 2013 Pages: 9 - 9
HIV-1 vaccine protects against SHIV in rhesus macaques Newsletter Article 06 February 2013 Pages: 9 - 9
HAF in the battle against HIV-1 and Kaposi’s sarcoma Newsletter Article 06 February 2013 Pages: 10 - 10
Dofetilide promising in supraventricular arrhythmias Gill Keating Newsletter Article 06 February 2013 Pages: 11 - 12
Haloperidol/amitriptyline superior to risperidone in psychotic depression Newsletter Article 06 February 2013 Pages: 13 - 13
ACE inhibitors first-line in type 2 diabetes and hypertension Newsletter Article 06 February 2013 Pages: 14 - 14
NCEP treatment goals supported by clinical trial data Newsletter Article 06 February 2013 Pages: 15 - 15
Long-term zolmitriptan well tolerated and effective in migraine Newsletter Article 06 February 2013 Pages: 16 - 16
Warfarin improves survival in LV systolic dysfunction Newsletter Article 06 February 2013 Pages: 16 - 16
Cabergoline improves gonadal function in macroprolactinoma Newsletter Article 06 February 2013 Pages: 17 - 17
Venlafaxine effective for anxiety in major depression Newsletter Article 06 February 2013 Pages: 18 - 18
Addition of IL-2/IFN-α of little benefit in metastatic melanoma Newsletter Article 06 February 2013 Pages: 18 - 18
Factors associated with sulfonylurea failure in diabetes Newsletter Article 06 February 2013 Pages: 18 - 18
Hartford nomogram valid in trauma surgery patients Newsletter Article 06 February 2013 Pages: 20 - 20
Increased asthma mortality also linked with β-agonists in Japan Newsletter Article 06 February 2013 Pages: 21 - 21